v3.26.1
Interim Condensed Consolidated Statements of Changes in Equity (Unaudited) - USD ($)
$ in Thousands
Issued capital [member]
Contributed Surplus [Member]
Reserve of share-based payments [member]
Reserve For Warrants [member]
Accumulated deficit [member]
Shareholders' equity [member]
Non-controlling interests [member]
Total
Beginning balance, value at Aug. 31, 2024 $ 165,945 $ 9,151 $ 1,700 $ (121,893) $ 54,903 $ 11,136 $ 66,039
Beginning balance, shares at Aug. 31, 2024 280,190,736              
IfrsStatementLineItems [Line Items]                
Shares issued for share-based payments (Note 15) $ 1,141 (1,141)
Shares issued for share-based payments, shares 2,692,686              
Share-based compensation expense (Note 15) 2,027 2,027 2,027
Witholding tax impact on share-based payments (402) (402) (402)
Net (loss) income for the period (1,758) (1,758) 3,059 1,301
Ending balance, value at May. 31, 2025 $ 167,086 9,635 1,700 (123,651) 54,770 14,195 68,965
Ending balance, shares at May. 31, 2025 282,883,422              
IfrsStatementLineItems [Line Items]                
Shares issued for share-based payments (Note 15) $ 915 (915)
Shares issued for share-based payments, shares 1,978,473              
Share-based compensation expense (Note 15) 434 434 434
Witholding tax impact on share-based payments (376) (376) (376)
Net (loss) income for the period 2,445 2,445 2,820 5,265
Ending balance, value at Aug. 31, 2025 $ 168,001 8,778 1,700 (121,206) 57,273 17,015 74,288
Ending balance, shares at Aug. 31, 2025 284,861,895              
IfrsStatementLineItems [Line Items]                
Shares issued for share-based payments (Note 15) $ 2,037 (2,037)
Shares issued for share-based payments, shares 4,360,778              
Share-based compensation expense (Note 15) 1,802 1,802 1,802
Shares issued for cash (Notes 14 and 15) $ 16 16 16
Shares issued for cash, shares 19,408              
Stock options exercised (Notes 14 and 15) $ 1,914 (904) 1,010 1,010
Stock options exercised, shares 3,579,619              
Warrants exercised (Notes 14 and 15) $ 53,204 (638) 52,566 52,566
Warrants exercised, shares 34,652,309              
Transfer from warrants reserves (Note 16) 1,062 (1,062)
Transfer from stock option reserves (Note 15) 21 (21)
Fees paid to brokers (Notes 14 and 15) (1,389) (1,389) (1,389)
Witholding tax impact on share-based payments (1,248) (1,248) (1,248)
Net (loss) income for the period (21,705) (21,705) 15,803 (5,902)
Ending balance, value at May. 31, 2026 $ 223,783 $ 1,083 $ 6,370 $ (142,911) $ 88,325 $ 32,818 $ 121,143
Ending balance, shares at May. 31, 2026 327,474,009